Evidence map›Paper›PMID 42670547›Full record

ArticleSurgical case reports2026

A Case of Long-Term Survival after Multimodal Treatments including Living-Donor Liver Transplantation for a Primary Neuroendocrine Tumor of the Bile Duct.

Akihito Jo, Akira Umemura, Hiroyuki Nitta, Satoshi Amano, Taro Ando, Toma Kawashima, Koji Kikuchi, Taku Kimura, Ayaka Sato, Naoki Yanagawa and 1 more

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akihito JoDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Akira UmemuraDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Hiroyuki NittaDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Satoshi AmanoDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Taro AndoDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Toma KawashimaDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Koji KikuchiDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Taku KimuraDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Ayaka SatoDepartment of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Naoki YanagawaDepartment of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.
Akira SasakiDepartment of Surgery, School of Medicine, Iwate Medical University, Shiwa-gun, Iwate, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAn extrahepatic biliary neuroendocrine tumor (EB-NET) is an extremely rare malignancy with a poor prognosis and no established standard of care. CASE PRESENTATION: We herein report the case of a 35-year-old Japanese woman with no significant past medical or family history who presented with epigastric and back pain and was diagnosed with an EB-NET after pylorus-preserving pancreaticoduodenectomy. Despite initial resection, she developed recurrent liver metastases that required repeated hepatic resections and multiple systemic therapies, including chemotherapy, somatostatin analogs, everolimus, and peptide receptor radionuclide therapy (PRRT). Eventually, owing to progressive liver metastasis, she underwent living-donor liver transplantation (LDLT) from her brother 6 years after the initial surgery. Post-transplantation, the patient has remained disease-free for >3 years while on maintenance immunosuppression.

conclusionsMultimodal treatment, including resection of metastases, PRRT, and LDLT, significantly prolonged survival. This case highlights the potential role of LDLT as a curative strategy for patients with EB-NETs and controlled extrahepatic disease following multimodal treatment. Our case suggests that liver transplantation may provide long-term survival even in cases of a rare primary EB-NET, prompting the consideration of broader transplant indications in selected patients.

Indexed as

extrahepatic biliary neuroendocrine tumorliver metastasesliver transplantationneuroendocrine tumor

Identifiers

PMID42670547
PMCPMC13526518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.